Noticias de ARCT_US

Noticias del mercado

Últimas noticias sobre ARCT_US — 92 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ARCT_US ✕ 92 resultados
27/04/2026 ARCT_US — ChartMill
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
27/04/2026 ARCT_US — news.google.com
Press Release: Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
27/04/2026 ARCT_US — Business Wire
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
27/04/2026 ARCT_US — Yahoo Finance
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
26/04/2026 ARCT_US — Stock Traders Daily
How Arcturus Therapeutics Holdings Inc. (ARCT) Affects Rotational Strategy Timing

Solo acción del precio: los movimientos de Arcturus Therapeutics Holdings Inc. (ARCT) marcan la pauta para los modelos institucionales. Cómo Arcturus Therapeutics Holdings Inc. (ARCT) afecta el momento de la estrategia rotacional

25/04/2026 ARCT_US — MEXC Exchange ES ← EN
Precio de ARCT hoy: Precio, cotización y gráfico de acciones de Arcturus Therapeutics Holdings Inc. | MEXC

El precio ARCT en vivo hoy es de 8,31 USD. Realice un seguimiento de ARCT en MEXC con gráficos en vivo, movimientos diarios, estadísticas clave e información esencial sobre la negociación de acciones.

24/04/2026 ARCT_US — MSN ES ← EN
El precio objetivo de Arcturus Therapeutics Holdings (ARCT) disminuyó un 27,17% a 25,78

Arcturus Therapeutics Holdings (ARCT) price target decreased by 27.17% to 25.78

24/04/2026 ARCT_US — MSN ES ← EN
El precio objetivo de Arcturus Therapeutics Holdings (ARCT) disminuyó un 27,17% a 25,78

Arcturus Therapeutics Holdings (ARCT) price target decreased by 27.17% to 25.78

24/04/2026 ARCT_US — Stock Titan
Arcturus (NASDAQ: ARCT) schedules 2026 virtual meeting on pay, board and auditor

Arcturus convoca una reunión totalmente virtual el 5 de junio de 2026 para elegir ocho directores, realizar una votación consultiva sobre el pago y ratificar a Deloitte como auditor de 2026 para 28,4 millones de acciones.

23/04/2026 ARCT_US — MSN
Arcturus Therapeutics Holdings (ARCT) price target decreased by 27.17% to 25.78
23/04/2026 ARCT_US — MSN ES ← EN
El precio objetivo de Arcturus Therapeutics Holdings (ARCT) disminuyó un 27,17% a 25,78

Arcturus Therapeutics Holdings (ARCT) price target decreased by 27.17% to 25.78

17/04/2026 ARCT_US — MarketBeat
Diversify Advisory Services LLC Sells 115,500 Shares of Arcturus Therapeutics Holdings Inc. $ARCT
16/04/2026 ARCT_US — DirectorsTalk Interviews
Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Navigating a 170% Potential Upside with Innovative Biotechnology
14/04/2026 ARCT_US — MarketBeat
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Rating of "Moderate Buy" from Brokerages
10/04/2026 ARCT_US — MarketBeat
Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below Two Hundred Day Moving Average - What's Next?
02/04/2026 ARCT_US — DirectorsTalk Interviews
Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a 196.82% Potential Upside with Cutting-Edge RNA Therapies
01/04/2026 ARCT_US — Stock Titan
ARCT SEC Filings - Arcturus Therape 10-K, 10-Q, 8-K Forms
28/03/2026 ARCT_US — Investing.com Australia
Cathie Wood’s ARK sells Nvidia stock, buys Arcturus Therapeutics By Investing.com
28/03/2026 ARCT_US — Investing.com South Africa
Cathie Wood’s ARK sells Nvidia stock, buys Arcturus Therapeutics By Investing.com
27/03/2026 ARCT_US — Investing.com
Cathie Wood’s ARK sells Nvidia stock, buys Arcturus Therapeutics

Página 3 de 5

keyboard_arrow_up